Attached files

file filename
10-Q - QUARTERLY REPORT - PROCTER & GAMBLE Cod10q.htm
EX-11 - COMPUTATION OF EARNINGS PER SHARE - PROCTER & GAMBLE Codex11.htm
EX-3.2 - REGULATIONS - PROCTER & GAMBLE Codex32.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - PROCTER & GAMBLE Codex321.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - PROCTER & GAMBLE Codex311.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - PROCTER & GAMBLE Codex322.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - PROCTER & GAMBLE Codex312.htm
EXCEL - IDEA: XBRL DOCUMENT - PROCTER & GAMBLE CoFinancial_Report.xls

EXHIBIT 12

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

 

 

Amounts in millions    Years Ended June 30    Three Months Ended
September 30
     2009(1)    2008(1)    2007(1)    2006(1)    2005(1)    2009(2)    2008(2)

EARNINGS, AS DEFINED

                    

Earnings from operations before income taxes and before adjustments for minority interests in consolidated subsidiaries and after eliminating undistributed earnings of equity method investees

   $ 15,372    $ 15,674    $ 14,299    $ 12,087    $ 9,512    $ 4,162    $ 4,292

Fixed charges (excluding capitalized interest)

     1,567      1,604      1,428      1,242      924      355      406
                                                

TOTAL EARNINGS, AS DEFINED

   $ 16,939    $ 17,278    $ 15,727    $ 13,329    $ 10,436    $ 4,517    $ 4,698
                                                

FIXED CHARGES, AS DEFINED

                    

Interest expense (including capitalized interest)

   $ 1,431    $ 1,546    $ 1,374    $ 1,153    $ 869    $ 341    $ 398

 1/3 of rental expense

     177      137      124      122      90      44      34
                                                

TOTAL FIXED CHARGES, AS DEFINED

   $ 1,608    $ 1,683    $ 1,498    $ 1,275    $ 959    $ 385    $ 432
                                                

RATIO OF EARNINGS TO FIXED CHARGES

     10.5x      10.3x      10.5x      10.5x      10.9x      11.7x      10.9x

 

(1) Amounts include the results of the Pharmaceuticals business.
(2) Amounts exclude the results of the Pharmaceuticals business, separately presented in the Consolidated Financial Statements as discontinued operations.